Eligible Patients for HSCB
home delivery scheme
Patients eligible for the service are those defined as being extremely vulnerable should they become infected with Covid-19. (This has previously been referred to as “the shielded group” although shielding for these patients has been paused for now.)
This definition may be subject to change; you will be advised of any changes which will also be published online at:
Patients should have been notified via a letter, sent out by their general practice or hospital consultant, and will be asked to contact their pharmacy if they need to have their prescriptions delivered.
Eligible groups of patients include :
- Housebound patients in receipt of a care package, which includes medication prompting
People with specific cancers:
- People with cancer who are undergoing active chemotherapy or radical radiotherapy for lung cancer.
- People with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment.
- People having immunotherapy or other continuing antibody treatments for cancer.
- People having other targeted cancer treatments which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors.
- Solid organ transplant recipients
- People on immunosuppression therapies sufficient to significantly increase risk of infection.
- People who have had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs.
- People with severe respiratory conditions including all cystic fibrosis, severe asthma and severe COPD.
- People with rare diseases and inborn errors of metabolism that significantly increase the risk of infections (such as SCID, homozygous sickle cell).
- People who are pregnant with significant congenital heart disease.